CBIO - Gyre Therapeutics Inc
Close
0.51
0.510 100.000%
Share volume: 0
Last Updated: Mon 30 Oct 2023 08:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
2.75%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
27%
Profitability
8%
Dept financing
6%
Liquidity
72%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 31-Dec-2018 - 31-Dec-2022
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-38.48%
Return on assets
-18.36%
Return on sales
-1208.75%
Return on invested capital
98.23%
Total debt ratio
18.42%
Debt ratio change over timeo
-0.89%
Current Ratio
9.22%
Quick Ratio
7.55%
Cash Position Ratio
5.5%
Short-term ratios 31-Dec-2021 - 31-Dec-2022
The data are presented for the financials results of the quarters of the last year.
Return on equity
-88.28%
Return on assets
-19.24%
Return on sales
-1851.51%
Return on invested capital
-335.77%
Total debt ratio
25.59%
Debt ratio change over timeo
-0.91%
Current Ratio
10.43%
Quick Ratio
10.43%
Cash Position Ratio
8.87%
Last quarter ratios 31-Dec-2022
The data are presented for the financials results of the last quarter.
Return on equity
-348.14%
Return on assets
-16.96%
Return on sales
0%
Return on invested capital
243.9%
Total debt ratio
59.15%
Debt ratio change over time
-0.89%
Current Ratio
1.68%
Quick Ratio
1.68%
Cash Position Ratio
1.29%
Performance ratios (change over 4 years) 31-Dec-2018 - 31-Dec-2022
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-117.05%
Return on assets
-110.79%
Return on sales
-1058.27%
Return on invested capital
25.24%
Total debt ratio
-89.31%
Debt ratio change over time
-0.89%
Current Ratio
4.14%
Quick Ratio
1.9%
Cash Position Ratio
2.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CBIO | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -38.48% | 0% | 0% | -80% |
| Return on assets | -18.36% | 0% | 0% | -10.88% |
| Return on sales | -1208.75% | 0% | 0% | -4386.38% |
| Return on invested capital | 98.23% | 0% | 0% | 27.15% |
| Profitability | 25% | 0% | 75% | 7% |
| Total debt ratio | 18.42% | 0% | 0% | 80.52% |
| Debt ratio change over time | -0.89% | 0% | 0% | -0.49% |
| Dept financing | 6% | 0% | 25% | 25% |
| Current Ratio | 10.43% | 0% | 0% | 9.61% |
| Quick Ratio | 10.43% | 0% | 0% | 9.61% |
| Cash Position Ratio | 8.87% | 0% | 0% | 9.44% |
| Liquididy | 68% | 0% | 0% | 71% |
| Short-term ratios | CBIO | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -88.28% | 0% | 0% | -446.05% |
| Return on assets | -19.24% | 0% | 0% | -11.77% |
| Return on sales | -1851.51% | 0% | 0% | -9485.53% |
| Return on invested capital | -335.77% | 0% | 0% | -97.72% |
| Profitability | 0% | 0% | 100% | 0% |
| Total debt ratio | 25.59% | 0% | 0% | 95.58% |
| Debt ratio change over time | -0.91% | 0% | 0% | -2.02% |
| Dept financing | 7% | 0% | 25% | 25% |
| Current Ratio | 10.43% | 0% | 0% | 9.61% |
| Quick Ratio | 10.43% | 0% | 0% | 9.61% |
| Cash Position Ratio | 8.87% | 0% | 0% | 9.44% |
| Liquididy | 73% | 0% | 0% | 71% |